These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23701539)

  • 1. Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia.
    Stasiak A; Mussur M; Unzeta M; Samadi A; Marco-Contelles JL; Fogel WA
    Curr Pharm Des; 2014; 20(2):161-71. PubMed ID: 23701539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central histamine level in rat model of vascular dementia.
    Stasiak A; Mussur M; Unzeta M; Lazewska D; Kiec-Kononowicz K; Fogel WA
    J Physiol Pharmacol; 2011 Oct; 62(5):549-58. PubMed ID: 22204803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.
    Bautista-Aguilera OM; Samadi A; Chioua M; Nikolic K; Filipic S; Agbaba D; Soriano E; de Andrés L; Rodríguez-Franco MI; Alcaro S; Ramsay RR; Ortuso F; Yañez M; Marco-Contelles J
    J Med Chem; 2014 Dec; 57(24):10455-63. PubMed ID: 25418133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia.
    Sakr HF; Khalil KI; Hussein AM; Zaki MS; Eid RA; Alkhateeb M
    J Physiol Pharmacol; 2014 Feb; 65(1):41-53. PubMed ID: 24622829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease.
    Esteban G; Allan J; Samadi A; Mattevi A; Unzeta M; Marco-Contelles J; Binda C; Ramsay RR
    Biochim Biophys Acta; 2014 Jun; 1844(6):1104-10. PubMed ID: 24642166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole alkaloids and semisynthetic indole derivatives as multifunctional scaffolds aiming the inhibition of enzymes related to neurodegenerative diseases--a focus on Psychotria L. Genus.
    Klein LC; Passos CS; Moraes AP; Wakui VG; Konrath EL; Nurisso A; Carrupt PA; de Oliveira CM; Kato L; Henriques AT
    Curr Top Med Chem; 2014; 14(8):1056-75. PubMed ID: 24660679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia.
    Kwon KJ; Kim MK; Lee EJ; Kim JN; Choi BR; Kim SY; Cho KS; Han JS; Kim HY; Shin CY; Han SH
    J Neurol Sci; 2014 Dec; 347(1-2):66-77. PubMed ID: 25266713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
    Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
    Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
    Weinstock M; Bejar C; Wang RH; Poltyrev T; Gross A; Finberg JP; Youdim MB
    J Neural Transm Suppl; 2000; (60):157-69. PubMed ID: 11205137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
    Weinstock M; Kirschbaum-Slager N; Lazarovici P; Bejar C; Youdim MB; Shoham S
    Ann N Y Acad Sci; 2001 Jun; 939():148-61. PubMed ID: 11462767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of carnosine, a histamine precursor in rat model of bilateral common carotid artery occlusion-induced vascular dementia.
    Tiwari N; Bhatia P; Kumar A; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2018 Oct; 32(5):516-531. PubMed ID: 29676814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Rhazya stricta Decne on monoamine oxidase and cholinesterase activity and brain biogenic amine levels in rats.
    Ali BH; Tanira MO; Bashir AK; Al-Qarawi AA
    J Pharm Pharmacol; 2000 Oct; 52(10):1297-300. PubMed ID: 11092575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo evaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system.
    Esteban G; Van Schoors J; Sun P; Van Eeckhaut A; Marco-Contelles J; Smolders I; Unzeta M
    J Pharm Pharmacol; 2017 Mar; 69(3):314-324. PubMed ID: 28134992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
    Estrada Valencia M; Herrera-Arozamena C; de Andrés L; Pérez C; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Viña D; Yáñez M; Laurini E; Pricl S; Rodríguez-Franco MI
    Eur J Med Chem; 2018 Aug; 156():534-553. PubMed ID: 30025348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
    Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
    Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.